Vaccination for Emergency Pathogens in Pregnancy: How to Protect Mothers and Infants

Microlearning Series

This case-based module is built around a realistic clinical scenario involving a 29-year-old pregnant patient at 28 weeks’ gestation, who presents with increasing concern following a local Chikungunya outbreak and reports of severe neonatal outcomes in her community. Using this scenario as a starting point, the module centers on a critical clinical question:

How can the safety of vaccination during pregnancy, for both mother and baby, be evaluated in the context of an emerging infectious disease?

Developed together with leading expert Prof. Beate Kampmann, the module explores how clinicians can navigate urgent decision-making by weighing disease risk, potential vaccine benefits, and evolving evidence to support informed, patient-centered care.

START LEARNING TODAY

What you will explore

  • Clinical decision-making in vaccination during pregnancy in outbreak settings
  • Balancing disease risk, vaccine benefits, limited clinical trial data and ethical considerations
  • Evidence-based counselling under uncertainty
STEP INTO THE CASE